Unmade: media and marketing analysis

Unmade: media and marketing analysis

Share this post

Unmade: media and marketing analysis
Unmade: media and marketing analysis
ARN's takeover bid for SCA is on the critical list; can it be saved?
Copy link
Facebook
Email
Notes
More

ARN's takeover bid for SCA is on the critical list; can it be saved?

Tim Burrowes
May 13, 2024
∙ Paid
4

Share this post

Unmade: media and marketing analysis
Unmade: media and marketing analysis
ARN's takeover bid for SCA is on the critical list; can it be saved?
Copy link
Facebook
Email
Notes
More
Share

Welcome to a special briefing for Unmade’s paying members on the latest developments in ARN Media’s attempt to plunder its rival Southern Cross Austereo.

Below the paywall, you’ll find the coupon code for members-only pricing for this month’s HumAIn conference on the impact of AI on the media and marketing world.

Unmade’s paying members support our analytical journalism. In return you get access to our full archive which goes behind the paywall after two months. You also get discounts on tickets to our events, including our forthcoming AI conference humAIn, our retail media conference, REmade and a free ticket to our annual Compass series.



Anchorage got spooked; here’s what ARN needs to do now to make the Southern Cross Austereo takeover happen

The metaphorical cupcakes were already being iced for this morning’s annual general meeting of ARN Media when things fell apart at the end of last week.

Instead of welcoming shareholders to the shiny new ARN offices in North Sydney with news that the company was ready to close the deal, the plan to take over rival Southern Cross Austereo is in tatters. It’s not quite dead, but an awful lot will now need to go right if it is to be saved. We’ll get some strong signals today whether shareholders have the patience for CEO Ciaran Davis and chairman Hamish McLennan to attempt to thread the needle.

Davis: Fighting to keep the deal alive

Here’s where we’re at:

Plan A: The Anchorage proposal

ARN’s scheme to swoop on Southern Cross Austereo and take its best parts, goes back the best part of year. In June 2023, ARN dropped $38.3m on buying a 14.8% stake in its main rival.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Unmade Pty Ltd
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More